Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews · Pregnancy and Childbirth

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 0 · 0%Moderate 2 · 66.7%High 0 · 0%

Ambroxol vs corticosteroid (betamethasone)

Incidence of RDS frequency in newborns · women at risk of preterm birth

Ambroxol showed no clear difference in incidence of RDS frequency in newborns compared with corticosteroid (betamethasone) (moderate certainty).

1 finding from 1 review

Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome 2014 · Cochrane Headline outcomes only
RR 0.79 [0.59, 1.07]
7 studies · 758 participants
Moderate

Ambroxol vs corticosteroid (betamethasone)

Perinatal mortality frequency of deaths of newborns · women at risk of preterm birth

Ambroxol showed no clear difference in perinatal mortality frequency of deaths of newborns compared with corticosteroid (betamethasone) (moderate certainty).

1 finding from 1 review

Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome 2014 · Cochrane Headline outcomes only
RR 0.51 [0.23, 1.12]
6 studies · 657 participants
Moderate

Ambroxol vs corticosteroid (betamethasone)

Adverse effects in pregnant women frequency in pregnant women · women at risk of preterm birth

It is very uncertain whether ambroxol changes adverse effects in pregnant women frequency in pregnant women compared with corticosteroid (betamethasone) (very low certainty).

1 finding from 1 review

Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress syndrome 2014 · Cochrane Headline outcomes only
RR 3.45 [0.34, 35.51]
3 studies · 305 participants
Very low